company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:14:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,49475000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:14:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,49475000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:14:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,875000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:14:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,875000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:14:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,48600000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:14:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9243000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:14:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2813000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:14:30+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,34516000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:14:30+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,2306000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:14:30+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,5687000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:14:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,54565000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:14:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5965000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:14:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,66000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:14:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,126000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:14:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,192000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:14:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5773000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:14:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1847000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:14:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3926000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:14:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3926000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:14:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3926000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:14:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30200000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:14:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:14:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30200000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:14:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:14:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30200000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:14:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:36:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,50617000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:36:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,50617000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:36:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,775000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:36:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,775000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:36:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,49842000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:36:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10517000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:36:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2873000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:36:46+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,42083000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:36:46+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,9000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:36:46+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,9626000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:36:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,65108000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:36:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15266000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:36:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,53000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:36:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-650000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:36:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-597000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:36:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15863000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:36:46+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-5972000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:36:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9891000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:36:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9891000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:36:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9891000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:36:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30000000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:36:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.33
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:36:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30000000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:36:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.33
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:36:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30000000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:36:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.33
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,56947000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,56947000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1402000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1402000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,55545000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11412000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2604000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,41542000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,951000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,127000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,56636000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1091000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,39000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,39000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1091000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,376000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1467000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1467000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1467000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29300000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29300000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29300000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 13:02:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:14:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,53877000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:14:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,53877000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:14:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,791000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:14:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,791000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:14:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,53086000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:14:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10030000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:14:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1910000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:14:30+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,41186000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:14:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,53126000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:14:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-40000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:14:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:14:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-296000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:14:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-292000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:14:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-332000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:14:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,236000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:14:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-568000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:14:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-568000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:14:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-568000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:14:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28400000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:14:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:14:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28400000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:14:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:14:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28400000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q2,2011-04-01,2011-06-30,2011-08-09 16:14:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,2011-11-09 16:36:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,50229000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,2011-11-09 16:36:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,50229000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,2011-11-09 16:36:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,646000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,2011-11-09 16:36:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,646000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,2011-11-09 16:36:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,49583000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,2011-11-09 16:36:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10821000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,2011-11-09 16:36:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1608000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,2011-11-09 16:36:46+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,45388000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,2011-11-09 16:36:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,57817000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,2011-11-09 16:36:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8234000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,2011-11-09 16:36:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-114000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,2011-11-09 16:36:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,773000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,2011-11-09 16:36:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,659000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,2011-11-09 16:36:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7575000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,2011-11-09 16:36:46+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1723000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,2011-11-09 16:36:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5852000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,2011-11-09 16:36:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5852000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,2011-11-09 16:36:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5852000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,2011-11-09 16:36:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30800000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,2011-11-09 16:36:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.19
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,2011-11-09 16:36:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30800000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,2011-11-09 16:36:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.19
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,2011-11-09 16:36:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30800000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q3,2011-07-01,2011-09-30,2011-11-09 16:36:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.19
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,46592000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,46592000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,718000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,718000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,45874000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8808000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1817000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,40354000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,21342000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,320000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,72641000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26767000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,675000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,241000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-439000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-873000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27640000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-3231000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24409000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24409000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24409000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29961000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.82
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29961000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.82
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29961000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.82
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,53695000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,53695000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1099000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1099000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,52596000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9846000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,373000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,39670000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,3967000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,688000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,54544000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1948000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,142000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-792000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-934000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2882000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,925000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3807000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3807000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3807000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29300000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29300000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29300000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 13:02:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,2012-08-20 16:54:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,50009000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,2012-08-20 16:54:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,50009000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,2012-08-20 16:54:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,753000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,2012-08-20 16:54:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,753000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,2012-08-20 16:54:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,49256000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,2012-08-20 16:54:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9841000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,2012-08-20 16:54:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,231000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,2012-08-20 16:54:22+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,36251000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,2012-08-20 16:54:22+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1439000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,2012-08-20 16:54:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47762000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,2012-08-20 16:54:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1494000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,2012-08-20 16:54:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-113000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,2012-08-20 16:54:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,136000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,2012-08-20 16:54:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,23000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,2012-08-20 16:54:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1517000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,2012-08-20 16:54:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1260000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,2012-08-20 16:54:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,257000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,2012-08-20 16:54:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,257000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,2012-08-20 16:54:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,257000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,2012-08-20 16:54:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25700000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,2012-08-20 16:54:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.01
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,2012-08-20 16:54:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25700000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,2012-08-20 16:54:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.01
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,2012-08-20 16:54:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,25700000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q2,2012-04-01,2012-06-30,2012-08-20 16:54:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.01
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,2012-11-09 12:23:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,55770000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,2012-11-09 12:23:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,55770000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,2012-11-09 12:23:56+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,621000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,2012-11-09 12:23:56+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,621000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,2012-11-09 12:23:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,55149000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,2012-11-09 12:23:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10774000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,2012-11-09 12:23:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,196000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,2012-11-09 12:23:56+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,43660000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,2012-11-09 12:23:56+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,2012-11-09 12:23:56+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1616000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,2012-11-09 12:23:56+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,2012-11-09 12:23:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,56246000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,2012-11-09 12:23:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1097000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,2012-11-09 12:23:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-109000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,2012-11-09 12:23:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-445000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,2012-11-09 12:23:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-554000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,2012-11-09 12:23:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1651000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,2012-11-09 12:23:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,492000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,2012-11-09 12:23:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2143000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,2012-11-09 12:23:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2143000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,2012-11-09 12:23:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2143000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,2012-11-09 12:23:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30414000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,2012-11-09 12:23:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,2012-11-09 12:23:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30414000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,2012-11-09 12:23:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,2012-11-09 12:23:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30414000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q3,2012-07-01,2012-09-30,2012-11-09 12:23:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,67212000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,67212000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,670000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,670000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,66542000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10443000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,106000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,48483000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,4367000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,889000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,64288000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2254000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,321000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,231000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,971000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,881000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3135000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1703000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1432000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1432000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1432000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30318000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.05
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30318000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.05
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30318000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.05
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,59406000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,59406000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1114000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1114000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,58292000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9549000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,105000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,37822000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,534000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,879000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,48889000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9403000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-82000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,452000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,370000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9773000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3268000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6505000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6505000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6505000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30650000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30650000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.21
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30650000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q1,2013-01-01,2013-03-31,2013-05-09 16:00:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:12:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,59292000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:12:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,59292000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:12:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,569000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:12:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,569000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:12:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,58723000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:12:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12454000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:12:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,171000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:12:00+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,42450000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:12:00+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,906000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:12:00+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4953000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:12:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,60934000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:12:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2211000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:12:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-81000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:12:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,321000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:12:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,240000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:12:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1971000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:12:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,276000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:12:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2247000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:12:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2247000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:12:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2247000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:12:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30872000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:12:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:12:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30872000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:12:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:12:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30872000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q2,2013-04-01,2013-06-30,2013-08-08 17:12:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:23:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,60755000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:23:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,60755000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:23:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,571000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:23:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,571000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:23:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,60184000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:23:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9249000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:23:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,94000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:23:15+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,44548000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:23:15+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:23:15+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,276000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:23:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,54167000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:23:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6017000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:23:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,138000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:23:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,155000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:23:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,17000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:23:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6034000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:23:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2332000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:23:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3702000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:23:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3702000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:23:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3702000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:23:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31041000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:23:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.12
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:23:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31041000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:23:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.12
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:23:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31041000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:23:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.12
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,67122000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,67122000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,513000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,513000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,66609000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11004000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,44000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,47103000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,417000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1075000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59643000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6966000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1423000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,174000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,150000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1099000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5867000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2059000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3808000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3808000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3808000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30912000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.12
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30912000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30912000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.12
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,59321000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,59321000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,593000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,593000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,58728000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10629000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,79000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,40325000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,230000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,51263000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7465000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2616000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-40000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2656000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4809000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1309000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3500000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3500000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3500000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31282000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.11
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31282000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31282000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:52:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.11
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:23:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,68179000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:23:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,68179000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:23:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,424000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:23:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,424000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:23:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,67755000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:23:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12747000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:23:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,128000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:23:04+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,45038000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:23:04+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,3718000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:23:04+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1042000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:23:04+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:23:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,62673000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:23:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5082000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:23:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3065000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:23:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-192000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:23:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3257000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:23:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1825000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:23:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1899000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:23:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3724000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:23:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3724000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:23:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3724000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:23:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31000000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:23:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.12
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:23:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33900000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:23:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:23:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31000000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:23:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.12
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 15:15:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,62471000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 15:15:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,62471000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 15:15:39+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,260000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 15:15:39+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,260000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 15:15:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,62211000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 15:15:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11568000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 15:15:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,568000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 15:15:39+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,56414000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 15:15:39+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1232000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 15:15:39+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2164000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 15:15:39+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 15:15:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,71946000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 15:15:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9735000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 15:15:39+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2575000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 15:15:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,235000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 15:15:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2340000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 15:15:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12075000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 15:15:39+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-3434000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 15:15:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8641000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 15:15:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8641000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 15:15:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8641000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 15:15:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31631000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 15:15:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 15:15:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31631000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 15:15:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 15:15:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31631000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 15:15:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,-189971000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,-189971000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-1277000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-1277000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-188694000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,-34944000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,-775000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-141777000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,-4950000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-3436000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-185882000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2812000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-8256000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,8253000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5441000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4024000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1417000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1417000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-734000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2151000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.05
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,81816000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,81816000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,382000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,382000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,81434000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17474000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,490000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,58139000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,2615000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1487000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,80205000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1229000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3036000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,469000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2567000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1338000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,885000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2223000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2223000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2223000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32827000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32827000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32827000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 17:19:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:01:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,89548000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:01:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,89548000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:01:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,179000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:01:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,179000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:01:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,89369000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:01:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16518000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:01:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,384000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:01:35+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,64668000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:01:35+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:01:35+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1632000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:01:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,83202000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:01:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6167000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:01:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3179000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:01:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,634000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:01:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2545000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:01:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3622000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:01:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1315000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:01:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2307000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:01:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2307000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:01:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2307000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:01:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32124000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:01:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.07
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:01:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32124000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:01:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.07
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:01:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32124000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 16:01:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.07
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:40:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,104579000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:40:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,104579000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:40:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-6000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:40:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-6000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:40:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,104585000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:40:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21219000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:40:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1903000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:40:12+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,80204000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:40:12+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,540000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:40:12+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,709000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:40:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,104575000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:40:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:40:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6318000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:40:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,798000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:40:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5520000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:40:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5510000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:40:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1340000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:40:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4170000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:40:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4170000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:40:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4170000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:40:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34800000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:40:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:40:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34800000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:40:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:40:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34800000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:40:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,-275943000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,-275943000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-555000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-555000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-275388000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,-55211000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,-2777000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-203011000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,-3155000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-3828000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-267982000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7406000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-12533000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1901000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,10632000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3226000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-860000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4086000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4086000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4086000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.12
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.12
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.12
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:40:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,152738000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:40:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,152738000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:40:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:40:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,152738000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:40:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,37304000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:40:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4642000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:40:12+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,123486000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:40:12+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:40:12+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2967000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:40:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,168399000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:40:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15661000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:40:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12714000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:40:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-549000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:40:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13263000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:40:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28924000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:40:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-5499000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:40:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23425000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:40:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23425000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:40:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23425000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:40:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41100000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:40:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.57
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:40:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41100000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:40:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.57
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:40:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41100000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:40:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.57
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,-152738000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,-152738000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-152738000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,-37304000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,-4642000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-123486000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-2967000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-168399000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,15661000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-12714000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,549000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,13263000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,28924000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5499000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,23425000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,23425000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,23425000.0
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.57
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.57
Albany Molecular Research Inc,AMRI,CHZJRCSC4ACUSUD2MV11,0001065087,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.57
